NDC-11 (Package) | NDC-9 (Product) (Descending) | Generic Name | Brand Name | Strength | SEER*Rx Category | Major Class | Minor Class | Administration Route | Package Effective Date | Package Discontinuation Date | Status |
---|---|---|---|---|---|---|---|---|---|---|---|
58463-0010-08 | 58463-0010 | dexamethasone | Decadron | 0.5 mg/5mL | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | March 15, 2018 | In Use | |
58181-3043-05 | 58181-3043 | Lomustine | Gleostine | 5.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrosourea | Oral | Nov. 5, 2015 | June 30, 2018 | No Longer Used |
58181-3042-05 | 58181-3042 | Lomustine | Gleostine | 100.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrosourea | Oral | Aug. 18, 2014 | In Use | |
58181-3041-05 | 58181-3041 | Lomustine | Gleostine | 40.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrosourea | Oral | Aug. 18, 2014 | In Use | |
58181-3040-05 | 58181-3040 | Lomustine | Gleostine | 10.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrosourea | Oral | Aug. 18, 2014 | In Use | |
58181-3032-05 | 58181-3032 | Lomustine | Lomustine | 100.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrosourea | Oral | Sept. 27, 2013 | Jan. 14, 2016 | No Longer Used |
58181-3031-05 | 58181-3031 | Lomustine | Lomustine | 40.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrosourea | Oral | July 29, 2014 | Jan. 14, 2016 | No Longer Used |
58181-3030-05 | 58181-3030 | Lomustine | Lomustine | 10.0 mg/1 | Chemotherapy | Alkylating Agent | Nitrosourea | Oral | July 29, 2014 | Jan. 14, 2016 | No Longer Used |
58178-0017-01 | 58178-0017 | Amifostine | Ethyol | Ancillary Therapy | Chemoprotective | Detoxifying Agent | Dec. 8, 1995 | April 30, 2012 | No Longer Used | ||
58178-0017-03 | 58178-0017 | Amifostine | Ethyol | Ancillary Therapy | Chemoprotective | Detoxifying Agent | Dec. 8, 1995 | April 30, 2012 | No Longer Used | ||
58177-0932-03 | 58177-0932 | Prednisolone Sodium Phosphate | Prednisolone Sodium Phosphate | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Jan. 1, 2009 | May 7, 2010 | No Longer Used | |
58177-0932-05 | 58177-0932 | Prednisolone Sodium Phosphate | Prednisolone Sodium Phosphate | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Jan. 1, 2009 | July 13, 2011 | No Longer Used | |
58177-0932-07 | 58177-0932 | Prednisolone Sodium Phosphate | Prednisolone Sodium Phosphate | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Jan. 1, 2009 | May 7, 2010 | No Longer Used | |
58177-0931-03 | 58177-0931 | Prednisolone Sodium Phosphate | Prednisolone Sodium Phosphate | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | Jan. 1, 2009 | June 22, 2011 | No Longer Used | |
58177-0910-05 | 58177-0910 | Prednisolone | Prednisolone | 15.0 mg/5mL | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | May 10, 2004 | In Use | |
58177-0910-07 | 58177-0910 | Prednisolone | Prednisolone | 15.0 mg/5mL | Hormonal Therapy | Adrenal Glucocorticoid | Corticosteroid | Oral | May 10, 2004 | In Use | |
58177-0364-22 | 58177-0364 | Ondansetron | Ondansetron | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Aug. 1, 2009 | June 28, 2011 | No Longer Used | |
58177-0364-56 | 58177-0364 | Ondansetron | Ondansetron | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Aug. 1, 2009 | June 28, 2011 | No Longer Used | |
58177-0363-22 | 58177-0363 | Ondansetron | Ondansetron | Ancillary Therapy | Antiemetic | 5HT3 Receptor Antagonist | Oral | Aug. 1, 2009 | June 28, 2011 | No Longer Used | |
58160-0830-01 | 58160-0830 | Human Papillomavirus Bivalent Vaccine, Recombinant | Cervarix | 20.0 ug/.5mL, 20.0 ug/.5mL | Ancillary Therapy | Protective Agent | HPV Vaccine | Intramuscular | Oct. 16, 2009 | Aug. 24, 2012 | No Longer Used |
58160-0830-05 | 58160-0830 | Human Papillomavirus Bivalent Vaccine, Recombinant | Cervarix | 20.0 ug/.5mL, 20.0 ug/.5mL | Ancillary Therapy | Protective Agent | HPV Vaccine | Intramuscular | March 20, 2012 | Nov. 29, 2016 | No Longer Used |
58160-0830-11 | 58160-0830 | Human Papillomavirus Bivalent Vaccine, Recombinant | Cervarix | 20.0 ug/.5mL, 20.0 ug/.5mL | Ancillary Therapy | Protective Agent | HPV Vaccine | Intramuscular | Oct. 16, 2009 | Aug. 24, 2012 | No Longer Used |
58160-0830-32 | 58160-0830 | Human Papillomavirus Bivalent Vaccine, Recombinant | Cervarix | 20.0 ug/.5mL, 20.0 ug/.5mL | Ancillary Therapy | Protective Agent | HPV Vaccine | Intramuscular | Oct. 16, 2009 | Sept. 3, 2013 | No Longer Used |
58160-0830-34 | 58160-0830 | Human Papillomavirus Bivalent Vaccine, Recombinant | Cervarix | 20.0 ug/.5mL, 20.0 ug/.5mL | Ancillary Therapy | Protective Agent | HPV Vaccine | Intramuscular | March 20, 2012 | Nov. 29, 2016 | No Longer Used |
58160-0830-41 | 58160-0830 | Human Papillomavirus Bivalent Vaccine, Recombinant | Cervarix | 20.0 ug/.5mL, 20.0 ug/.5mL | Ancillary Therapy | Protective Agent | HPV Vaccine | Intramuscular | July 25, 2011 | Sept. 3, 2013 | No Longer Used |
Found 10,000 results in 10 milliseconds — Export these results